Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD Mice

Abstract

This work provides demonstration of the essential prodiabetogenic activities of IL-21 on diverse genetic backgrounds (NOD and C57BL/6) and indicates that IL-21 blockade could be a promising strategy for interventions in human type 1 diabetes.